Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

US Breast Cancer Screening Market to Reach US$ 5.8 Billion by 2022.

DPI Research
Posted on: 11 Aug 17

United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022.

Buy Now: http://www.dpiresearch.com/report-details.php?P_ID=107

Long–term Growth Projection:

• Mammography grasp the dominant share in the United States Breast Cancer Screening Market
 
• Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
 
• Number of mammograpy screening population in United States will increase to
    more than 50 Million by 2022

Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.

“United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.

Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.


The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products and latest development and trends 

Key Topics Covered in the Report

• United States Breast Cancer Cases (2010 - 2022)
• United States Breast Cancer Mammography Screening Population (2010 – 2022)
• United States Breast Cancer Death (2010 – 2017)
• Market Overview: United States Breast Cancer Screening (2010 – 2022)
• Market Share: United States Breast Cancer Screening (2010 – 2022)
• By Types (Mammography, Breast MRI & Breast Ultrasound): Market Size & Analysis (2010 – 2022)
• Reimbursement Policies of the United States Breast Cancer Screening
• Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
• Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
• Key Manufacturers Analysis


Major Breast Cancer Screening Analyzed Under This Report Are:

• Mammography
• Breast Magnetic Resonance Imaging(MRI)
• Breast Ultrasound

Browse the full report at: http://www.dpiresearch.com/report-details.php?P_ID=107

Major Companies Covered in This Report:

• Hitachi Medical Corporation
• Siemen Healthineers
• Philips Healthcare 
• Toshiba Medical Systems Corporation
• GE Healthcare
• Hologic

Contact Us:
Maria Rai
Tel :+91 -7289949987
Email: sales@dpiresearch.com
Website: www.dpiresearch.com

For more information:
www.dpiresearch.com/report-details.php?P_ID=107

Editor's Details

Sajid Jamal
DPI Research
www.dpiresearch.com
(+91) 7289949987
sales@dpiresearch.com

Last updated on: 11/08/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.